Atara Biotherapeutics Stock Forecast

Buy or Hold candidate since Apr 30, 2026 Gain 101.68%

The Atara Biotherapeutics stock price fell by -3.41% on the last day (Tuesday, 16th Jun 2026) from $9.96 to $9.62. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 9.28% from a day low at $9.21 to a day high of $10.07. The price has fallen in 6 of the last 10 days and is down by -2.83% for this period. Volume has increased on the last day by 46 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 126 thousand shares were bought and sold for approximately $1.21 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 133.07% during the next 3 months and, with a 90% probability hold a price between $18.91 and $29.75 at the end of this 3-month period.

ATRA Signals & Forecast

The Atara Biotherapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $9.95. On a fall, the stock will find some support from the long-term average at approximately $8.83. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -14.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Atara Biotherapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Atara Biotherapeutics stock

Atara Biotherapeutics finds support from accumulated volume at $9.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.85 between high and low, or 9.28%. For the last week, the stock has had daily average volatility of 8.48%.

Our recommended stop-loss: $9.12 (-5.18%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (ATRA) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Atara Biotherapeutics to open at $9.63, and during the day (based on 14 day Average True Range), to move between $9.20 and $10.04, which gives a possible trading interval of +/-$0.85 (+/-9.23%) up or down from last closing price. If Atara Biotherapeutics takes out the full calculated possible swing range there will be an estimated 9.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.81 (1.98%) than the support at $9.15 (4.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Atara Biotherapeutics stock A Buy?

Atara Biotherapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.773 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $9.63 ( 0.123%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk